Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Razelle Kurzrock, Tamas Hickish, Lucjan Wyrwicz, Mark Saunders, Qian Wu, Michael Stecher, Prasant Mohanty, Charles A. Dinarello & John Simard. (2019) Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer. OncoImmunology 8:3.
Read now
Read now
Maryse Dagenais, Jeremy Dupaul-Chicoine, Todd Douglas, Claudia Champagne, Alexandre Morizot & Maya Saleh. (2017) The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis. OncoImmunology 6:3.
Read now
Read now
Steven P. Cercy & Brian Bronson. (2010) Putative Mechanisms of Cognitive Dysfunction in Chemotherapy-Naïve Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature. Applied Neuropsychology 17:3, pages 223-233.
Read now
Read now
Magdalena Chechlinska, Maria Kowalska & Janina Kaminska. (2008) Cytokines as potential tumour markers. Expert Opinion on Medical Diagnostics 2:6, pages 691-711.
Read now
Read now
Articles from other publishers (35)
Helene Hersvik Aarstad, Svein Erik Emblem Moe, Stein Lybak, Øystein Bruserud, Tor Henrik Anderson Tvedt & Hans Jørgen Aarstad. (2024) Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival. Cancers 16:8, pages 1484.
Crossref
Crossref
Constantin-Dan Tâlvan, Liviuța Budișan, Elena-Teodora Tâlvan, Valentin Grecu, Oana Zănoagă, Cosmin Mihalache, Victor Cristea, Ioana Berindan-Neagoe & Călin Ilie Mohor. (2024) Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer. Cancers 16:4, pages 745.
Crossref
Crossref
Zhenyu Xie, Xin Li, Yuzhen He, Song Wu, Shiyue Wang, Jianjian Sun, Yuchen He, Yu Lun, Shijie Xin & Jian Zhang. (2020) Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods. BMC Cancer 20:1.
Crossref
Crossref
Helene Hersvik Aarstad, Svein Erik Emblem Moe, Øystein Bruserud, Stein Lybak, Hans Jørgen Aarstad & Tor Henrik Anderson Tvedt. (2020) The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles. Biomedicines 8:10, pages 418.
Crossref
Crossref
Zhihao Lu, Jianling Zou, Ying Hu, Shuang Li, Tao Zhou, Jifang Gong, Jian Li, Xiaotian Zhang, Jun Zhou, Ming Lu, Xicheng Wang, Zhi Peng, Changsong Qi, Yanyan Li, Jie Li, Yan Li, Jianyin Zou, Xiao Du, Henghui Zhang & Lin Shen. (2019) Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer. JAMA Network Open 2:7, pages e197621.
Crossref
Crossref
Kelly Yi Ping Liu, Xian Jun David Lu, Yuqi Sarah Zhu, Nhu Le, Hugh Kim & Catherine F. Poh. (2018) Plasma-Derived Inflammatory Proteins Predict Oral Squamous Cell Carcinoma. Frontiers in Oncology 8.
Crossref
Crossref
Yuan-Chang Yang, Wing-Ming Chou, Debora Arny Widowati, I-Ping Lin & Chi-Chung Peng. (2018) 10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells. BMC Complementary and Alternative Medicine 18:1.
Crossref
Crossref
Masaya Yotsukura, Takashi Ohtsuka, Kaoru Kaseda, Ikuo Kamiyama, Yuichiro Hayashi & Hisao Asamura. (2016) Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer. Journal of Thoracic Oncology 11:8, pages 1311-1318.
Crossref
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology
17
61
.
Norio Kanzaki, Shunichi Ishii & Masaaki Suzuki. (2013) Analysis of postoperative survival in patients with gastric cancer surgery based on the modified Glasgow Prognostic Score胃癌手術症例におけるmodified Glasgow Prognostic Score（mGPS）を用いた長期予後に関する検討. The Japanese Journal of SURGICAL METABOLISM and NUTRITION 47:6, pages 177-184.
Crossref
Crossref
Noemí Eiró. (2012) Inflammation and cancer. World Journal of Gastrointestinal Surgery 4:3, pages 62.
Crossref
Crossref
Tommaso Iannitti & Beniamino Palmieri. (2011) Inflammation and Genetics: An Insight in the Centenarian Model. Human Biology 83:4, pages 531-559.
Crossref
Crossref
Charles A. Dinarello. (2010) Why not treat human cancer with interleukin-1 blockade?. Cancer and Metastasis Reviews 29:2, pages 317-329.
Crossref
Crossref
Minako Kobayashi, Yasuhiro Inoue, Yasuhiko Mohri, Chikao Miki & Masato Kusunoki. (2010) Implementing a standard protocol to decrease the incidence of surgical site infections in rectal cancer surgery. Surgery Today 40:4, pages 326-333.
Crossref
Crossref
Bharat B Aggarwal & Prashasnika Gehlot. (2009) Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 9:4, pages 351-369.
Crossref
Crossref
Shailendra Kapoor. (2008) Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients. Langenbeck's Archives of Surgery 394:2, pages 401-402.
Crossref
Crossref
F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni & M Magnani. (2008) Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. The Pharmacogenomics Journal 9:1, pages 78-84.
Crossref
Crossref
Chikao Miki, Masato Kusunoki, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri, John A. C. Buckels & Paul McMaster. (2008) Remodeling of the immunoinflammatory network system in elderly cancer patients: Implications of inflamm-aging and tumor-specific hyperinflammation. Surgery Today 38:10, pages 873-878.
Crossref
Crossref
Chikao Miki, Kouji Tanaka, Yasuhiro Inoue, Toshimitsu Araki, Masaki Ohi, Yasuhiko Mohri, Keiichi Uchida & Masato Kusunoki. (2008) Perioperative host-tumor inflammatory interactions: A potential trigger for disease recurrence following a curative resection for colorectal cancer. Surgery Today 38:7, pages 579-584.
Crossref
Crossref
Sebastian Niedźwiecki, Tomasz Stępień, Krzysztof Kuzdak, Henryk Stępień, Roman Krupiński, Daniel Seehofer, Nada Rayes & Frank Ulrich. (2007) Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients. Langenbeck's Archives of Surgery 393:3, pages 275-280.
Crossref
Crossref
A. Mustea, C. Pirvulescu, D. Könsgen, E.I. Braicu, S. Yuan, P. Sun, W. Lichtenegger & J. Sehouli. (2008) Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer. Cytokine 42:1, pages 77-84.
Crossref
Crossref
M. Inoue, C. Miki, Y. Okita, K. Otake, S. Yoshiyama, K. Uchida & M. Kusunoki. (2006) Naturally acquired regulatory mechanism of perioperative cytokine response in neonates. Pediatric Surgery International 23:3, pages 249-255.
Crossref
Crossref
Zhibin Hu, Minhua Shao, Yijiang Chen, Jiannong Zhou, Ji Qian, Lin Xu, Hongxia Ma, Xinru Wang, Yaochu Xu, Daru Lu & Hongbing Shen. (2006) Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Letters 236:2, pages 269-275.
Crossref
Crossref
J. Kaminska, M.P. Nowacki, M. Kowalska, A. Rysinska, M. Chwalinski, M. Fuksiewicz, W. Michalski & M. Chechlinska. (2005) Clinical Significance of Serum Cytokine Measurements in Untreated Colorectal Cancer Patients: Soluble Tumor Necrosis Factor Receptor Type I – An Independent Prognostic Factor. Tumor Biology 26:4, pages 186-194.
Crossref
Crossref
Chikao Miki, Yasuhiro Inoue, Yuji Toiyama, Eiki Ojima, Minako Kobayashi, Tsuyoshi Hatada, Toshimitsu Araki & Masato Kusunoki. (2005) Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma. Critical Care Medicine 33:1, pages 177-180.
Crossref
Crossref
Hubert Allgayer, Susanne Nicolaus & Stephan Schreiber. (2004) Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment. Cancer Detection and Prevention 28:3, pages 208-213.
Crossref
Crossref
H Knüpfer, R Schmidt, D Stanitz, M Brauckhoff, M Schönfelder & R Preiss. (2004) CYP2C and IL-6 expression in breast cancer. The Breast 13:1, pages 28-34.
Crossref
Crossref
Piotr Rutkowski, Janina Kamińska, Maria Kowalska, Wlodzimierz Ruka & Jan Steffen. (2003) Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis. Journal of Surgical Oncology 84:3, pages 151-159.
Crossref
Crossref
Ritsuto Fujiwaki, Kohji Iida, Kentaro Nakayama, Haruhiko Kanasaki, Kohkichi Hata, Hidetaka Katabuchi, Hitoshi Okamura & Kohji Miyazaki. (2003) Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecologic Oncology 89:1, pages 77-83.
Crossref
Crossref
Mario Roselli, Fiorella Guadagni, Francesca Martini, Antonella Spila, Sabrina Mariotti, Roberta D’Alessandro, Simona Aloe, Pier Paolo Gazzaniga, Stefania Basili, Maurizio Cosimelli & Patrizia Ferroni. (2003) Association between Serum Carcinoembryonic Antigen and Endothelial Cell Adhesion Molecules in Colorectal Cancer. Oncology 65:2, pages 132-138.
Crossref
Crossref
Eiji Minato, Chikao Miki, Kouji Tanaka, Minako Kobayashi, Yasuhiko Mohri, Hitoshi Tonouchi, Kagemasa Kuribayashi & Masato Kusunoki. (2002) Vascular endothelial growth factor as an age-dependent prognostic factor in gastric cancer patients. The American Journal of Surgery 184:5, pages 460-464.
Crossref
Crossref
Mansoor Abdul & Naseema Hoosein. (2002) RELATIONSHIP OF THE INTERLEUKIN-1 SYSTEM WITH NEUROENDOCRINE AND EXOCRINE MARKERS IN HUMAN COLON CANCER CELL LINES. Cytokine 18:2, pages 86-91.
Crossref
Crossref
I. Syk, P. Mangell, A. Bjartell & B. Jeppsson. (2002) Systemic Interleukin-6 Response to Colorectal Surgery Originates from the Bowel. Digestive Surgery 19:3, pages 210-215.
Crossref
Crossref
M. B??HM, A. ITTENSON, C. PHILIPP, F.-W. R??HL, S. ANSORGE & E. P. ALLHOFF. (2001) COMPLEX PERIOPERATIVE IMMUNO-DYSFUNCTION IN PATIENTS WITH RENAL CELL CARCINOMA. The Journal of Urology, pages 831-836.
Crossref
Crossref
M. BÖHM, A. ITTENSON, C. PHILIPP, F.-W. RÖHL, S. ANSORGE & E.P. ALLHOFF. (2001) COMPLEX PERIOPERATIVE IMMUNO-DYSFUNCTION IN PATIENTS WITH RENAL CELL CARCINOMA. Journal of Urology 166:3, pages 831-836.
Crossref
Crossref